Lillian B Brown1, Diane V Havlir, James Ayieko, Florence Mwangwa, Asiphas Owaraganise, Dalsone Kwarisiima, Vivek Jain, Theodore Ruel, Tamara Clark, Gabriel Chamie, Elizabeth A Bukusi, Craig R Cohen, Moses R Kamya, Maya L Petersen, Edwin D Charlebois. 1. aDivision of HIV, ID and Global Medicine bCenter for AIDS Prevention Studies, University of California, San Francisco, San Francisco, California, USA cKenya Medical Research Institute, Kwale, Kenya dInfectious Diseases Research Collaboration eDivision of HIV Prevention, Makerere University Joint AIDS Program, Kampala, Uganda fDepartment of Pediatrics, Division of Infectious Diseases gDepartment of Obstetrics, Gynecology & Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, California, USA hSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda iDivision of Biostatistics and Epidemiology, University of California, Berkeley, Berkeley, California, USA.
Abstract
OBJECTIVE: We sought to measure retention in care and identify predictors of nonretention among patients receiving antiretroviral therapy (ART) with streamlined delivery during the first year of the ongoing Sustainable East Africa Research on Community Health (SEARCH) 'test-and-treat' trial (NCT 01864603) in rural Uganda and Kenya. DESIGN: Prospective cohort of patients in the intervention arm of the SEARCH study. METHODS: We measured retention in care at 12 months among HIV-infected adults who linked to care and were offered ART regardless of CD4 cell count, following community-wide HIV-testing. Kaplan-Meier estimates and Cox proportional hazards modeling were used to calculate the probability of retention at 1 year and identify predictors of nonretention. RESULTS: Among 5683 adults (age ≥15) who linked to care, 95.5% [95% confidence interval (CI): 92.9-98.1%] were retained in care at 12 months. The overall probability of retention at 1 year was 89.3% (95% CI: 87.6-90.7%) among patients newly linking to care and 96.4% (95% CI: 95.8-97.0%) among patients previously in care. Younger age and pre-ART CD4 cell count below country treatment initiation guidelines were predictors of nonretention among all patients. Among those newly linking, taking more than 30 days to link to care after HIV diagnosis was additionally associated with nonretention at 1 year. HIV viral load suppression at 12 months was observed in 4227 of 4736 (89%) of patients retained with valid viral load results. CONCLUSION: High retention in care and viral suppression after 1 year were achieved in a streamlined HIV care delivery system in the context of a universal test-and-treat intervention.
OBJECTIVE: We sought to measure retention in care and identify predictors of nonretention among patients receiving antiretroviral therapy (ART) with streamlined delivery during the first year of the ongoing Sustainable East Africa Research on Community Health (SEARCH) 'test-and-treat' trial (NCT 01864603) in rural Uganda and Kenya. DESIGN: Prospective cohort of patients in the intervention arm of the SEARCH study. METHODS: We measured retention in care at 12 months among HIV-infected adults who linked to care and were offered ART regardless of CD4 cell count, following community-wide HIV-testing. Kaplan-Meier estimates and Cox proportional hazards modeling were used to calculate the probability of retention at 1 year and identify predictors of nonretention. RESULTS: Among 5683 adults (age ≥15) who linked to care, 95.5% [95% confidence interval (CI): 92.9-98.1%] were retained in care at 12 months. The overall probability of retention at 1 year was 89.3% (95% CI: 87.6-90.7%) among patients newly linking to care and 96.4% (95% CI: 95.8-97.0%) among patients previously in care. Younger age and pre-ARTCD4 cell count below country treatment initiation guidelines were predictors of nonretention among all patients. Among those newly linking, taking more than 30 days to link to care after HIV diagnosis was additionally associated with nonretention at 1 year. HIV viral load suppression at 12 months was observed in 4227 of 4736 (89%) of patients retained with valid viral load results. CONCLUSION: High retention in care and viral suppression after 1 year were achieved in a streamlined HIV care delivery system in the context of a universal test-and-treat intervention.
Authors: Vivek Jain; Dathan M Byonanebye; Gideon Amanyire; Dalsone Kwarisiima; Doug Black; Jane Kabami; Gabriel Chamie; Tamara D Clark; James F Rooney; Edwin D Charlebois; Moses R Kamya; Diane V Havlir Journal: AIDS Date: 2014-09-24 Impact factor: 4.177
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Vivek Jain; Teri Liegler; Jane Kabami; Gabriel Chamie; Tamara D Clark; Douglas Black; Elvin H Geng; Dalsone Kwarisiima; Joseph K Wong; Mohamed Abdel-Mohsen; Nitin Sonawane; Francesca T Aweeka; Harsha Thirumurthy; Maya L Petersen; Edwin D Charlebois; Moses R Kamya; Diane V Havlir Journal: Clin Infect Dis Date: 2012-12-12 Impact factor: 9.079
Authors: Elvin H Geng; David V Glidden; Mwebesa Bosco Bwana; Nicolas Musinguzi; Nneka Emenyonu; Winnie Muyindike; Katerina A Christopoulos; Torsten B Neilands; Constantin T Yiannoutsos; Steven G Deeks; David R Bangsberg; Jeffrey N Martin Journal: PLoS One Date: 2011-07-26 Impact factor: 3.240
Authors: Tsitsi Mutasa-Apollo; Ray W Shiraishi; Kudakwashe C Takarinda; Janet Dzangare; Owen Mugurungi; Joseph Murungu; Abu Abdul-Quader; Celia J I Woodfill Journal: PLoS One Date: 2014-01-29 Impact factor: 3.240
Authors: Kara G Marson; Kenneth Tapia; Pamela Kohler; Christine J McGrath; Grace C John-Stewart; Barbra A Richardson; Julia W Njoroge; James N Kiarie; Samah R Sakr; Michael H Chung Journal: PLoS One Date: 2013-10-24 Impact factor: 3.240
Authors: Kudakwashe C Takarinda; Anthony D Harries; Ray W Shiraishi; Tsitsi Mutasa-Apollo; Abu Abdul-Quader; Owen Mugurungi Journal: Int J Infect Dis Date: 2014-11-15 Impact factor: 3.623
Authors: Gabriel Chamie; Tamara D Clark; Jane Kabami; Kevin Kadede; Emmanuel Ssemmondo; Rachel Steinfeld; Geoff Lavoy; Dalsone Kwarisiima; Norton Sang; Vivek Jain; Harsha Thirumurthy; Teri Liegler; Laura B Balzer; Maya L Petersen; Craig R Cohen; Elizabeth A Bukusi; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: Lancet HIV Date: 2016-01-26 Impact factor: 12.767
Authors: Lillian B Brown; James Ayieko; Florence Mwangwa; Asiphas Owaraganise; Dalsone Kwarisiima; Vivek Jain; Theodore Ruel; Tamara Clark; Douglas Black; Gabriel Chamie; Elizabeth A Bukusi; Craig R Cohen; Moses R Kamya; Maya L Petersen; Edwin D Charlebois; Diane V Havlir Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731
Authors: Paola Magro; Carlo Cerini; Aldorada da Gloria; Stelio Tembe; Francesco Castelli; Lina Rachele Tomasoni Journal: Trop Med Int Health Date: 2021-09-12 Impact factor: 3.918
Authors: Colette Guiteau Moise; Vanessa R Rivera; Kelly A Hennessey; Clovy Bellot; Chris Nicholas; Anna P Fang; Rose Irène Verdier; Patrice Severe; Alix Sainvil; Benedict Charles; Derothy Dorval; Juseline St Amour; Jean W Pape; Serena P Koenig Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731
Authors: Serena P Koenig; Nancy Dorvil; Jessy G Dévieux; Bethany L Hedt-Gauthier; Cynthia Riviere; Mikerlyne Faustin; Kerlyne Lavoile; Christian Perodin; Alexandra Apollon; Limathe Duverger; Margaret L McNairy; Kelly A Hennessey; Ariadne Souroutzidis; Pierre-Yves Cremieux; Patrice Severe; Jean W Pape Journal: PLoS Med Date: 2017-07-25 Impact factor: 11.069
Authors: Saeed Ahmed; Rachael A Sabelli; Katie Simon; Nora E Rosenberg; Elijah Kavuta; Mwelura Harawa; Spencer Dick; Frank Linzie; Peter N Kazembe; Maria H Kim Journal: Trop Med Int Health Date: 2017-06-20 Impact factor: 2.622
Authors: Kate R Murray; Lisa S Dulli; Kathleen Ridgeway; Leila Dal Santo; Danielle Darrow de Mora; Patrick Olsen; Hannah Silverstein; Donna R McCarraher Journal: PLoS One Date: 2017-09-29 Impact factor: 3.240